National Research Corporation
NRC

$403.08 M
Marketcap
$17.17
Share price
Country
$0.10
Change (1 day)
$42.18
Year High
$16.74
Year Low

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

marketcap

P/B ratio for National Research Corporation (NRC)

P/B ratio as of 2023: 19.83

According to National Research Corporation's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.83. At the end of 2022 the company had a P/B ratio of 12.91.

P/B ratio history for National Research Corporation from 1993 to 2023

P/B ratio at the end of each year

Year P/B ratio
2023 19.83
2022 12.91
2021 12.37
2020 16.73
2019 49.74
2018 54.14
2017 10.06
2016 5.56
2015 5.23
2014 3.86
2013 6.33
2012 3.05
2011 3.09
2010 3.43
2009 3.64
2008 3.33
2007 3.44
2006 4.57
2005 5.18
2004 5.17
2003 5.64
2002 6.36
2001 7.45
2000 8.15
1999 9.60
1998 11.98
1997 11.95
1996 74.03
1995 82.00
1994 92.46
1993 517.45